Department of Defense
OFFICE OF STRATEGIC INITIATIVES - CALL FOR SUBMISSIONS
U.S. Army Medical Research and Materiel Command (USAMRMC) Broad Agency Announcement - BAA -15-1
Apply early. Funding is limited and subject to availability.
The BAA is continuously open, and accepts proposals on a rolling basis. Pre-proposals may be submitted and will be evaluated at any time throughout the year.
Scope: The USAMRMC's mission is to provide solutions to medical problems of importance to the American warfighter. Projects must pertain to at least one of the research areas of interest outlined in the BAA.
Funding: Budgets are not capped and must reflect the scope of the work. Funding can be requested for up to 5 years.
Areas of interest:
1. Military Infectious Diseases Research Program
2. Combat Casualty Care Research Program
3. Military Operational Medicine Research Program
4. Clinical and Rehabilitative Medicine Research Program
5. Medical Biological Defense Research Program
6. Medical Chemical Defense Research Program
7. Medical Simulation and Information Sciences Research Program
8. Radiation Health Effects Research Program
9. Special Investment Areas/Innovation Funding
Office of Strategic Initiatives (OSI): Case School of Medicine's OSI can work with you to make sure that you meet the current goals and objectives of the USAMRMC that is paramount for your success. OSI can assist you in preparing a competitive proposal and can help guide your efforts from the first draft of the pre-proposal to submission of the full application.
Timeline: Invitation to submit a Full proposal will be given within 90 days of submission of the pre-proposal. An additional 90 days is provided to the applicant to complete the full application. Allow for at least 6 months between submission of the whitepaper to submission of the full application.
Contact us: If you are planning on submitting a pre-proposal, have questions, or would like more information - contact OSI Project Manager Irene Shaland - email@example.com - 216.368.4970
National Center for Accelerated Innovations (NCAI)
The Office of Translation and Innovation will host an information session on the National Center for Accelerated Innovations (NCAI) program, including details on the current RFA, led by Mark Low, Managing Director for the NCAI-Cleveland Clinic and Mark Chance, Vice Dean for Research in the CWRU School of Medicine.
The information session will be held next Monday, January 26 from 12n - 1pm in BRB 932.
All interested investigators are encouraged to attend. If you are coming from outside the School of Medicine, please stop by the security desk on the ground floor of the Biomedical Research Building and they will give you access to the elevators.
Drs. Low and Chance, among others, will be on hand to help answer any questions you have about this innovations program. The NCAI is currently running it's third funding cycle RFA. This regional funding opportunity is a great chance to move your translational research project to the next level.
Letter of Intent deadline is February 10, 2015
Please RSVP to Anne DeChant or to firstname.lastname@example.org
For more information on the RFA visit the NCAI-CC website.
National Endowment for the Humanities (NEH)
The National Endowment for the Humanities has announced a new grant opportunity that encourages the publication of nonfiction books that apply serious humanities scholarship to subjects of general interest and appeal.
The new NEH Public Scholar awards support well-researched books in the humanities conceived and written to reach a broad readership. Books supported through this program might present a narrative history, tell the stories of important individuals, analyze significant texts, provide a synthesis of ideas, revive interest in a neglected subject, or examine the latest thinking on a topic. Most importantly, they should open up important and appealing subjects for wider audiences by presenting significant humanities topics in a way that is accessible to general readers.
The Public Scholar program is open to both independent scholars and individuals affiliated with scholarly institutions. It offers a stipend of $4,200 per month for a period of six to twelve months. The maximum stipend is $50,400 for a twelve-month period. Applicants must have previously published a book or monograph with a university or commercial press, or articles and essays that reach a wide readership.
Application Deadline for first cycle: March 3, 2015
For more information visit the NEH website.
The Cleveland StrokeNet is offering a Clinical Research and Training Award focused on training in research methodologies and conduct of research related to cerebrovascular diseases. The Cleveland StrokeNet is a collaboration of clinical cerebrovascular programs at University Hospitals of Cleveland, Cleveland Clinic, MetroHealth Medical Center, and Louis Stokes Cleveland VA Medical Center and is funded by the National Institutes of Neurological Disorders and Stroke (NINDS).
This Clinical Research and Training Award is open to clinical and/or research fellows, postdoctoral fellows and faculty within 5 years of training who wish to devote a significant portion of their career to methodologically rigorous research. It is designed to provide research support to allow the investigator to obtain external grant funding in an area of cerebrovascular research, which could include (but are not limited to) primary prevention, acute management, mechanisms of ischemia, genetics, rehabilitation and recovery, and secondary prevention.
The investigator must spend 50% of their effort on research during the period of the award. Applications are due February 1, 2015.
Send the attached completed application and (2) current CV to Irene Katzan MD at email@example.com.
NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC)
The NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC)
Announces the Request for Applications (RFA) for the third funding cycle.
Funding is available for promising emerging technologies directed towards diagnosis, treatment or management of cardiovascular, pulmonary, blood or sleep-related disorders. NCAI-CC is seeking projects such as therapeutics (e.g. drugs, biologics), preventatives, diagnostics, devices, tools, etc., in order to facilitate their translation to commercialized products that improve patient care and enhance health. The NCAI-CC will provide funding and project assistance to advance the development of high priority early-stage technologies within the mission areas of the NHLBI (cardiovascular, lung, blood and sleep disorders). Expert assistance will be provided in areas required for early technology development, including commercial opportunity assessment, intellectual property, clinical and regulatory, reimbursement, business, legal and project management.
Eligibility: Investigators from the Cleveland Clinic, Case Western Reserve University, The Ohio State University,Cincinnati Children’s Hospital, and University of Cincinnati
Letter of Intent Deadline: February 10, 2015
For more information visit the NCAI-CC website.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be